Connect with us

Technology

DR. DAVID AMRON TESTIFIES BEFORE U.S. SENATE SPECIAL COMMITTEE ON AGING ON AI-ENABLED FRAUD TARGETING OLDER AMERICANS

Published

on

Internationally Recognized Lipedema Surgeon Shares Firsthand Experience with AI-Generated Medical Impersonation and Calls for Stronger Protections for Patients

LOS ANGELES, Aug. 3, 2026 /PRNewswire/ — On Wednesday, July 29, 2026, Dr. David Amron, Founder and Medical Director of The Roxbury Institute and Founder and Chair of The Lipedema Society, appeared before the U.S. Senate Special Committee on Aging to testify during “The AI Deception Machine: Deepfakes, Chatbots, and the New Frontier of Senior Fraud.”

Dr. Amron joined Senate Special Committee on Aging Chairman Rick Scott, Ranking Member Kirsten Gillibrand, Senators Mark Kelly and Tommy Tuberville, other lawmakers, consumer advocates, cybersecurity experts, banking leaders, and a fraud victim to examine the growing threat artificial intelligence poses to older Americans.

Dr. Amron was invited to Washington to testify after his name, image, voice, and professional reputation were unlawfully used in a sophisticated AI-generated medical impersonation scam to promote a fraudulent so-called “miracle” lipedema cream. His appearance before the Committee focused on raising awareness, bringing the issue directly to Congress, and helping advance legislation to create stronger protections for patients, physicians, older Americans, and other consumers.

The deceptive advertisements incorporated authentic footage from Dr. Amron’s YouTube channel that was manipulated to make it appear he had endorsed the product. The scammers also created an entirely AI-generated likeness, image, and voice of his colleague, Dr. Karen Herbst, Head of Research and Director of Diagnostic and Preventative Medicine at The Roxbury Institute. AI-generated celebrity images and stolen media logos were also used to create polished advertisements that appeared entirely legitimate.

Several individuals purchased the fraudulent product before learning the advertisements were fabricated, including one of Dr. Amron’s own patients.

The scam first came to light after concerned patients began contacting The Roxbury Institute with questions about the advertisements. As soon as the fraud was identified, Dr. Amron and his team began investigating and reporting the coordinated scam to Facebook, the fraudulent social media accounts responsible for publishing the advertisements, the domain registrars hosting the websites, Google Ads, and the major search engines directing consumers to the scam.

Despite persistent reporting efforts, each time one version was removed, another quickly appeared, highlighting the limitations of existing reporting systems in combating coordinated AI-enabled fraud.

After exhausting every available reporting mechanism, Dr. Amron brought national attention to the issue through NBC’s TODAY Show, helping expose the sophisticated scam and educate consumers about the growing dangers of AI-generated medical impersonation.

The bipartisan Senate hearing examined how artificial intelligence is increasingly being exploited through deepfakes, voice cloning, chatbots, and other emerging technologies to target older Americans with sophisticated scams. Throughout the hearing, lawmakers and expert witnesses emphasized the urgent need for stronger consumer protections, greater accountability, improved public education, and enhanced collaboration between government and the private sector.

“What disturbed me most was not that someone had misused my image. It was knowing that scammers had used my name and reputation to deceive the very people I have dedicated my career to helping,” said Dr. David Amron. “This problem is no longer theoretical. It is happening right now, and the consequences for patient safety, medical ethics, and the integrity of healthcare information are profound.”

During his testimony, Dr. Amron warned that the consequences of AI-generated medical fraud extend far beyond financial loss. Patients may delay legitimate medical care for a progressive disease like lipedema, rely on products falsely presented as physician-endorsed, and allow their condition to worsen, and allow their condition to worsen.

Perhaps most damaging, these scams erode the trust patients place in their physicians, leaving them uncertain about whom they can trust for legitimate medical guidance.

Dr. Amron also urged Congress to improve accountability for those who create and distribute AI-generated impersonation scams and ensure that laws keep pace with rapidly advancing technology.

His testimony underscored the growing threat AI-enabled fraud poses not only to older Americans, but also to patient safety, medical ethics, and public trust in healthcare. By sharing his firsthand experience, Dr. Amron hopes to help drive meaningful policy solutions that better protect patients and consumers from increasingly sophisticated AI-generated deception.

For interviews or media inquiries, please contact:
Natalia Grazziani
Grazziani Communications
natalia@grazzianicommunications.com
323-646-1581

About The Roxbury Institute

The Roxbury Institute, founded by Dr. David Amron in Los Angeles, is a nationally recognized multidisciplinary center specializing in advanced treatment for individuals with fat disorders and those seeking aesthetic and medical dermatology care. Built on clinical excellence and innovative research, the Institute has offices in Salt Lake City and Tucson. Its specialties include advanced lipedema treatment, liposculpture, and revision liposuction, supported by divisions in Research, Diagnosis and Prevention, Advanced Lipedema Treatment, and Aesthetic Medicine and Dermatology. These programs address complex and often misunderstood conditions while advancing scientific knowledge, setting national standards of care, and providing evidence-based, patient-focused treatment. From diagnosis through long-term care, The Roxbury Institute reflects a commitment to enduring patient outcomes and comprehensive support.

To learn more, please visit: www.theroxburyinstitute.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/dr-david-amron-testifies-before-us-senate-special-committee-on-aging-on-ai-enabled-fraud-targeting-older-americans-302840440.html

SOURCE The Roxbury Institute

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

MEDIA ALERT: Equinix to Speak at Upcoming Investor Conferences

Published

on

By

REDWOOD CITY, Calif., Aug. 3, 2026 /PRNewswire/ — Equinix, Inc. (Nasdaq: EQIX), the world’s digital infrastructure company®, today announced that its executives will attend two upcoming investor conferences:

KeyBanc Technology Leadership Forum on Monday, August 10. Guy Danskine, Managing Director, Western United States, and Ryan Burke, Vice President, Investor Relations, will present at 9:00 a.m. MT.

TD Cowen 12th Annual Communications Infrastructure Summit on Tuesday, August 11. Raouf Abdel, Executive Vice President, Global Operations, will present at 12:25 p.m. MT.

The presentations will be made available via webcast on the Investor Relations section of the Equinix website at www.equinix.com/investors.

About Equinix
Equinix, Inc. (Nasdaq: EQIX) shortens the path to boundless connectivity anywhere in the world. Its digital infrastructure, data center footprint and interconnected ecosystems empower innovations that enhance our work, life and planet. Equinix connects economies, countries, organizations and communities, delivering seamless digital experiences and cutting-edge AI—quickly, efficiently and everywhere.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/media-alert-equinix-to-speak-at-upcoming-investor-conferences-302840492.html

SOURCE Equinix, Inc.

Continue Reading

Technology

NextPlat to Release Second Quarter 2026 Results on Thursday, August 13, 2026

Published

on

By

Investor Conference Call Scheduled for Thursday, August 13, 2026 at 8:30 a.m. Eastern

HALLANDALE BEACH, Fla., Aug. 3, 2026 /PRNewswire/ — NextPlat Corp (NASDAQ: NXPL) (“NextPlat” or the “Company”), a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels worldwide, today announced that it will release its financial results for the second quarter ended June 30, 2026 on August 13, 2026.

NextPlat’s CEO, President and CEO of Global Operations, David Phipps, its Chief Financial Officer, Amanda Ferrio and Vice President of Healthcare Operations, Birute Norkute will host a conference call on Thursday, August 13th at 8:30 a.m. Eastern to discuss the results for the second quarter ended June 30, 2026, as well as other recent developments. Investors are requested to submit their questions for the Q&A portion of the call prior to August 10, 2026, at investors@nextplat.com.

To access the call, please use the following information:

Date:

Thursday, August 13, 2026

Time:

8:30 a.m. Eastern time

Toll-free dial-in number:

1-877-407-9716

International dial-in number:

1-201-493-6779

Conference webcast

https://viavid.webcasts.com/starthere.jsp?ei=1770457&tp_key=6a139162d1

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization.

The conference call will be broadcast live and available for replay at https://viavid.webcasts.com/starthere.jsp?ei=1770457&tp_key=6a139162d1 and via the investor relations section of the Company’s website at https://ir.nextplat.com/news-events/ir-calendar. A replay of the conference call will be available after 12:00 p.m. Eastern time through August 27, 2026.

Toll-free replay number:

1-844-512-2921

International replay number:

1-412-317-6671

Access ID:

13761874

For more information about NextPlat, please visit www.NextPlat.com and connect with us on Facebook, LinkedIn and X.

About NextPlat Corp

NextPlat is a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels worldwide. Through acquisitions, joint ventures, and collaborations, the Company seeks to provide access to high quality healthcare and pharmacy services supporting patients, providers, institutions, and public-sector organizations and creating online sales channels for the sales of products to domestic and international consumers. Through its subsidiaries, NextPlat provides pharmacy and healthcare data management services and prescription fulfillment services in the United States and operates an e-commerce division offering voice, data, tracking, and IoT products and services worldwide.

Forward-Looking Statements

Certain statements in this release constitute forward-looking statements. These statements include the capabilities and success of the Company’s business and any of its products, services or solutions. The words “believe,” “forecast,” “project,” “intend,” “expect,” “plan,” “should,” “would,” and similar expressions and all statements, which are not historical facts, are intended to identify forward-looking statements. These forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors including its ability to grow and expand as intended, any of which could cause the Company to not achieve some or all of its goals or the Company’s previously reported actual results, performance (finance or operating), including those expressed or implied by such forward-looking statements. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (the “SEC”), copies of which may be obtained from the SEC’s website at www.sec.gov. The Company assumes no, and hereby disclaims any, obligation to update the forward-looking statements contained in this press release.

Media and Investor Contact for NextPlat Corp:
Michael Glickman
MWGCO, Inc.
917-397-2272
mike@mwgco.net

View original content to download multimedia:https://www.prnewswire.com/news-releases/nextplat-to-release-second-quarter-2026-results-on-thursday-august-13-2026-302840653.html

SOURCE NextPlat Corp.

Continue Reading

Technology

AGCO Aligns Leadership to Advance PTx™ Growth Strategy

Published

on

By

Damon Audia to lead PTx & Corporate Strategy;
Indira Agarwal appointed Senior Vice President, Chief Financial Officer

DULUTH, Ga., Aug. 3, 2026 /PRNewswire/ — AGCO Corporation (NYSE: AGCO) today announced a series of executive leadership changes effective August 1, 2026. Damon Audia, previously Senior Vice President, Chief Financial Officer, has been named President of PTx & Corporate Strategy, which encompasses AGCO’s precision agriculture business and the enterprise strategy and transformation teams. Indira Agarwal, previously Vice President, Chief Accounting Officer, has been appointed Senior Vice President, Chief Financial Officer. Brian Sorbe, who served as President of PTx, has decided to step away from AGCO to focus on other personal and professional priorities.

“Damon brings a deep understanding of our business and has partnered across every function to drive growth,” said Eric Hansotia, AGCO’s Chairman, President & CEO. “He has led significant transformation initiatives, including the formation of AGCO’s PTx Trimble™ Joint Venture, and serves as the Chairman of the PTx Trimble Joint Venture Board. His strong Farmer-First focus will help drive long-term, profitable growth for our precision ag business. I also want to thank Brian for his many contributions to AGCO and PTx™ and wish him well for the future.”

PTx is central to AGCO’s growth strategy, bringing together the company’s precision agriculture technology solutions and a significant opportunity to create more value for farmers as the trusted partner for industry-leading, smart farming solutions. Audia currently leads corporate strategy, which will move with him to PTx to help support one of AGCO’s most important growth levers.

Agarwal, who succeeds Audia as Chief Financial Officer, joined AGCO in 2024 as Chief Accounting Officer, where she has strengthened the rigor, speed and transparency of AGCO’s financial reporting and deepened the controls that protect the company and its shareholders. Agarwal has also helped drive AGCO’s transformation efforts focused on improving efficiency, strengthening structural profitability and advancing strategic Mergers & Acquisitions (M&A).

“Indira has been an outstanding leader for AGCO,” said Hansotia. “She brings vast global experience and deep expertise across accounting, financial reporting and M&A, along with a strong continuous-improvement mindset. She has earned the trust of her colleagues, our executive team and our Board, and I am confident she will provide strong leadership as we continue to execute our strategy and create value for our shareholders. Damon and Indira have worked closely together, and this transition places two experienced enterprise leaders in roles where their strengths are closely aligned with AGCO’s next phase of growth.”

Agarwal will also continue to lead AGCO’s accounting organization as Chief Accounting Officer while the company conducts a search for a successor.

Audia served as AGCO’s Chief Financial Officer since 2022, overseeing accounting, tax, treasury, M&A, Financial Planning & Analysis (FP&A), corporate reporting, strategy, investor relations, audit and communications. He previously held senior finance roles at Kennametal, Carpenter Technology Corporation and The Goodyear Tire & Rubber Company, as well as earlier financial leadership positions at Delphi Corporation and General Motors. He holds a Master of Business Administration (MBA) degree from Carnegie Mellon University and an undergraduate degree in general studies from the University of Michigan.

Agarwal brings more than 20 years of experience in corporate accounting, financial reporting, M&A and business integration, financial controls and regulatory compliance. Prior to joining AGCO, she served as Vice President, Chief Accounting Officer and Controller of HF Sinclair Corporation and also led the company’s FP&A organization. She previously held progressive finance leadership roles at HF Sinclair, Cardtronics and Direct Energy. She holds a bachelor’s degree in finance from Delhi University and is a Fellow of the Association of Chartered Certified Accountants (U.K.).

PTx and PTx Trimble are trademarks of AGCO.

About AGCO

AGCO (NYSE: AGCO) is a global leader in agricultural machinery and precision agriculture technologies. Driven by a Farmer-First strategy, AGCO delivers value through its differentiated leading brands, Fendt™, Massey Ferguson™, PTx™ and Valtra™.  AGCO’s high-performance equipment and smart farming solutions, including brand-agnostic retrofit technologies and autonomous offerings, empower farmers to drive productivity while sustainably feeding the world. For more information, visit www.agcocorp.com. 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/agco-aligns-leadership-to-advance-ptx-growth-strategy-302841096.html

SOURCE AGCO Corporation

Continue Reading

Trending